Garda to Acquire Assertio for ~$125.1M Upfront

Shots: Garda Therapeutics has entered into a definitive agreement to acquire Assertio, delisting it from Nasdaq As per the deal, Garda will acquire Assertio for $18/share in cash (~$125.1M) plus a non-tradeable CVR related to potential future milestones for Sprix, with the deal expected to close in Q2’26 & remaining shares acquired later via a…

ByRidhi Rastogi2 days ago

Lonza to Sell CHI Business to Lone Star Funds for ~$3B

Shots: Lonza has agreed to divest its Capsules & Health Ingredients (CHI) business to Lone Star Funds for an enterprise value of CHF 2.3B (~$3B), receiving CHF 1.7B (~$2.2B) upfront while retaining a 40% stake with preferential participation in future exit proceeds Lonza is expecting total undiscounted proceeds of ≥CHF 3B (~$4B) from CHI via…

ByRidhi RastogiMarch 9, 2026

Novartis AG to Transfer Stake in Novartis India Limited to ChrysCapital

Shots: Novartis AG has signed an agreement with ChrysCapital to divest its 70.68% stake in Novartis India Limited (NIL), following a strategic review initiated in Feb 2024 The transaction, subject to customary closing conditions, is expected to close in Q3’26; the Board of NIL was formally notified post-signing Post-divestment, Novartis will further its transition into…

ByRidhi RastogiFebruary 20, 2026

Garda to Acquire Assertio for ~$125.1M Upfront

Lonza to Sell CHI Business to Lone Star Funds for ~$3B

Novartis AG to Transfer Stake in Novartis India Limited to ChrysCapital

Contact US

FOLLOW US